Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits

Matthew J. Allen; Russell E. Jacobs; Thomas J Meade; Scott Fraser

Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits

Matthew J. Allen (Inventor), Russell E. Jacobs (Inventor), Thomas J Meade (Inventor), Scott Fraser (Inventor)

Chemistry

Research output: Patent

Abstract

The invention relates to a novel class of magnetic resonance imaging agents that can cross the blood brain barrier and provide accurate magnetic resonance imaging of the brain, especially magnetic resonance images of amyloid deposits associated with Alzheimer's disease.

Original language	English (US)
Patent number	7029655
Filing date	10/4/01
State	Published - Apr 18 2006

Cite this

@misc{591cbdf2937642c3acbf08d7867427d0,

title = "Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits",

abstract = "The invention relates to a novel class of magnetic resonance imaging agents that can cross the blood brain barrier and provide accurate magnetic resonance imaging of the brain, especially magnetic resonance images of amyloid deposits associated with Alzheimer's disease.",

author = "Allen, {Matthew J.} and Jacobs, {Russell E.} and Meade, {Thomas J} and Scott Fraser",

note = "Filed: October 4, 2001; 7029655",

year = "2006",

month = apr,

day = "18",

language = "English (US)",

type = "Patent",

}

TY - PAT

T1 - Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits

AU - Allen, Matthew J.

AU - Jacobs, Russell E.

AU - Meade, Thomas J

AU - Fraser, Scott

N1 - Filed: October 4, 2001

PY - 2006/4/18

Y1 - 2006/4/18

N2 - The invention relates to a novel class of magnetic resonance imaging agents that can cross the blood brain barrier and provide accurate magnetic resonance imaging of the brain, especially magnetic resonance images of amyloid deposits associated with Alzheimer's disease.

AB - The invention relates to a novel class of magnetic resonance imaging agents that can cross the blood brain barrier and provide accurate magnetic resonance imaging of the brain, especially magnetic resonance images of amyloid deposits associated with Alzheimer's disease.

M3 - Patent

M1 - 7029655

Y2 - 2001/10/04

ER -

Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits

Abstract

Fingerprint

Cite this